Kapanol (Morphine)
morphine sulfate pentahydrate 100 mg modified release capsule, 28 · ORAL · PBS code 12529K
AUTHORITY_REQUIREDWhat it costs
AU$38.99 PBS-determined price per 56 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2021-06-01.
- • Repeats: 0.
- • PBS program: PL.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Severe disabling pain
Patient must have had or would have inadequate pain management with maximum tolerated doses of non-opioid or other opioid analgesics; or
Patient must be unable to use non-opioid or other opioid analgesics due to contraindications or intolerance; AND
Patient must be undergoing palliative care.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 2
Authority requests for treatment duration up to 1 month may be requested through the Online PBS Authorities system or by calling Services Australia.
Authority requests extending treatment duration beyond 1 month may be requested through the Online PBS Authorities system or in writing and must not provide a treatment duration exceeding 3 months (quantity sufficient for up to 1 month treatment and sufficient repeats).
Sponsor: Mayne Pharma International Pty Ltd ABN 88 007 870 984
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.